Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism

Recruiting now · Not applicable

Conditions studied: Autism Spectrum Disorder

In brief

In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.

Key facts

Study ID

NCT03827941

Run by

Massachusetts General Hospital

People needed

40

Starts

2022-11-01

Expected to finish

2027-09-28

Last updated by the study team

2026-07-17

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Autism diagnosed based on DSM-V classification criteria
• 18-60 year old high functioning adult autism patients (e.g. Asperger's, IQ equal or greater than 80)
• Subjects who do not show aggressive behaviors based on neuro/psychiatric evaluations as determined by a licensed study physician.

You may not qualify if…

• A history of chronic serious infection, any current infection, any type of cancer or autoimmune disease or other severe diseases;
• Subjects taking any medications that confound the study results

Where it is running

• MGB — Charlestown, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.